Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting - Net Revenue and Operating Profit of Each Segment (Detail)

v3.5.0.2
Segment Reporting - Net Revenue and Operating Profit of Each Segment (Detail) - USD ($)
 3 Months Ended 6 Months Ended
May 31, 2016
May 31, 2015
May 31, 2016
May 31, 2015
Nov. 30, 2015
Segment Reporting Information [Line Items]          
Total net revenue $ 5,773,056 $ 5,013,889 $ 10,925,254 $ 9,857,270  
Total cost of sales 1,431,100 1,377,387 2,779,391 2,651,374  
Total depreciation and amortization 41,872 17,101 83,420 35,343  
Total operating income 882,384 602,091 1,038,806 1,227,282  
Total interest expense 343,463 $ 369,801 604,797 $ 671,087  
Total assets 20,469,328   20,469,328   $ 19,497,946
Umbilical Cord Blood and Cord Tissue Stem Cell Service [Member]          
Segment Reporting Information [Line Items]          
Total net revenue 5,349,745   10,370,204    
Total cost of sales 1,345,370   2,590,393    
Total depreciation and amortization 28,555   57,233    
Total operating income 915,052   1,056,069    
Total interest expense 335,589   582,532    
Total assets 17,741,253   17,741,253   16,697,621
Prepacyte CB [Member]          
Segment Reporting Information [Line Items]          
Total net revenue 66,379   198,118    
Total cost of sales 85,730   188,998    
Total depreciation and amortization 13,317   26,187    
Total operating income (32,668)   (17,263)    
Total interest expense 7,874   22,265    
Total assets $ 2,728,075   $ 2,728,075   $ 2,800,325